医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

PharmaEssentia to Present at the 41st Annual J.P. Morgan Healthcare Conference

2023年01月03日 PM10:00
このエントリーをはてなブックマークに追加


 

TAIPEI, Taiwan

PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, today announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023.

A link to the live audio webcast of the presentation will be available on the News page of the PharmaEssentia USA website at us.pharmaessentia.com. An audio replay will be available for 30 days following the presentation.

About PharmaEssentia

PharmaEssentia (TPEx: 6446), headquartered in Taipei, Taiwan, is a global and rapidly growing biopharmaceutical innovator. Leveraging deep expertise and proven scientific principles, PharmaEssentia aims to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one approved product and a diversifying pipeline. Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today PharmaEssentia is expanding its global presence with operations in the U.S., Japan, China, and Korea, along with a world-class biologics production facility in Taichung, Taiwan.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230103005200/en/

CONTACT

Rachel Lipsitz, rachel_lipsitz@pharmaessentia.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 3DHISTECH and Epredia Open Pathology Innovation Incubator to Accelerate Advancements in Cancer Diagnostics
  • OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1 Clinical Trial of Treatment of Androgenic Alopecia
  • Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application
  • Norges Bank Terminates Its Observation On Kirin Holdings
  • ホセ・バセルガ研究基金がプリオン病研究を前進させるための初の助成を発表